Pethidine, first used in 1940, has retained its position as the most widely used obstetrical analgesic (Burt, 1971 ; Jaffe & Martin, 1975; ODonoghue, 1971 ; O'Driscoll etal., 1973; Rosen, 1971) . The metabolismof pethidine in the pregnant woman gives rise to norpethidine, pethidinic acid and norpethidinic acid, and conjugated pethidinic acid and norpethidinic acid respectively. A simple t.1.c. procedure for the separation of this drug and its metabolites in urine is described. The procedure should be of use in biochemical and pharmacokinetic studies on pethidine and its metabolites, which are becoming increasingly important in modern therapeutics.
filter plug which retains sediment. The eluate is dried by filtering through Whatman SP1 paper and rotary-evaporated to dryness under reduced pressure at 40°C. The residue is dissolved in l O m l of 0.1 M-HCI and the pH is adjusted to 9.2 with 1 M-NaOH; this solution is extracted twice with equal volumes of 1,2-dichloroethane. The pooled extract is concentrated almost to dryness, again under reduced pressure at 40°C, and transferred to a 5 m l tapered tube with three washings of acetone/methanol (1 :1, v/v). The volume of this solution is then decreased to approx. 5 0~1 under N2 at 40°C. The resultant extract, which contains the unconjugated compounds, is hereinafter denoted extract I.
The aqueous phase remaining after the above extraction contains the conjugated metabolites. This phase is adjusted to pH4.5 with 0.1 M-HCI and buffered with 5ml of 0.5 M-sodium acetate (adjusted to pH4.5 with ~M -H C~) .
Then 8-glucuronidase is added [from Helix pomatia; 5000units/ml of original urine; Sigma (London) Chemical Co., London S.W.6, U.K.]; this preparation is particularly suitable as it contains not only B-glucuronidase, which hydrolyses the glucuronides, but also arylsulphatase, which hydrolyses the sulphates. Propan-I ,2-diol(2ml) is added to enhance enzyme activity, and 0.2ml of chloroform is added as a preservative. The solution is incubated at 37°C for 48h. The solution is then adjusted to pH9.2 and treated as above for the unconjugated compounds. The resultant extract, which contains pethidinic acid and norpethidinic acid that were originally conjugated, is denoted extract 11. Pure reference compounds of pethidine, norpethidine, pethidinic acid and norpethidinic acid (supplied by courtesy of Dr. H. T. Openshaw and Dr. E. Frisch, Wellcome Research Laboratories) were added to urine in the range I-10,ug and processed in the same way to give the standard extracts. A control urine sample with no additions should also be processed to give control extracts I and 11 respectively. In clinical trials this control should be an extract from a urine specimen collected before drug administration.
The drug and its metabolites in the various extracts are then separated by using the following t.1.c. procedure. Silica-gel G plates (20cmx 20cm; Merck, Darmstadt, Germany) are predeveloped with pursed methanol so that any possible interfering contaminants (which form a yellow band at the solvent front) can be removed with a spatula after drying. The plates are then divided into 1 cm lanes to permit concurrent VOl. 5 * These were treated as the conjugated metabolites, which were not available as reference processing of the various extracts in duplicate. These include the pre-drug-administration control extracts I and 11, the analytical extracts I and 11, and the standard reference extracts. The extracts are transferred completely with three sequential applications of approx. Sop1 of 1,2-dichloroethane/actone/methanol (2: 2: 1, by vol.)
to points 1.5cm from the: base of the plate. The plates are developed in an ascending manner by using methand/l7.5~-NH~ (200:3, v/v; solvent 1). When the solvent front reaches a premarked 15an level, the plate is removed and air-dried. It is then developed in the same direction with a second ascending mobile phase consisting of benzene/dioxan/17.5 M-NH, (65:35: 6, by vol.; solvent 2), and again air-dried. One marker lane containing the reference compounds is then sprayed with a modified Dragendorff's Reagent (7.5g of KI first added to 1 gof bismuth subcarbonate dissolved in 3 ml of conc. HCI; the solution is then made up to lOOml with glass-distilled water and refrigerated for storage). At the corresponding locations in the other lanes, areas for investigation are vacuum-removed to sintered glass discs. The various compounds are then eluted from the discs with several portions of acetone/methanol (1 :1, v/v). Pethidine and norpethidine can be determined by the dye-complexing procedure of Burns et al. (1955) , or by the more specific and sensitive g.1.c. procedure of O'DonoghueRyan (1975~). Pethidinic acid and norpethidinic acid must first, however, be esterified to pethidine and norpethidine respectively before being determined as described above. This can be carried out with ethanolic BF, (a reagent prepared by BDH Chemicals, Poole, Dorset, U.K., for this purpose). Reagent (1 ml) is added to the extract residue, and left at 65-70°C for 30min. Then glass-distilled water is added, the pH adjusted to 9.2 with 1 hi-NaOH, and pethidine and norpethidine, extracted as described above.
The Rp values (solvent 1 , solvent 2) for the reference compounds processed as described above are as follows: pethidine (0.85, 0.92); norpethidine (0.40, 0.52); pethidinic acid (0, 0.13); norpethidinic acid (0, 0). In practice the RF values for the first solvent are not required. The overall recovery of reference compounds after the treatment were also determined. These are summarized in Table 1 . In general, recoveries are some 5 %greater for additions of 10pg/20ml of urine, and some 5 % less for additions of 1 ,ug/20ml of urine, than those quoted in Table 1 . Interestingly, there are no losses of reference pethidinic acid and norpethidinic acid at the enzymic-hydrolysis stage (in contrast with an acid-hydrolytic procedure, where a lO-15% loss was observed) (Burns et al., 1955) . In clinical cases where combination therapy with pethidine and chlorpromazine (for example) is being used, the above t.1.c. procedure can still be used after a preliminary separation of pethidine (and its metabolites) from chlorpromazine (and its metabolites) by the method of ODonoghueRyan (19756) .
